American National Bank & Trust’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06K Hold
76
﹤0.01% 590
2025
Q4
$853 Hold
76
﹤0.01% 669
2025
Q3
$879 Buy
+76
New +$890 ﹤0.01% 621
2015
Q3
Sell
-26
Closed -$1K 256
2015
Q2
$1K Hold
26
﹤0.01% 282
2015
Q1
$1K Sell
26
-7
-21% -$324 ﹤0.01% 265
2014
Q4
$2K Buy
+33
New +$1.3K ﹤0.01% 264

Other funds holding AVNS

American National Bank & Trust's AVNS Position: Q1 2026 in Review

American National Bank & Trust held its Avanos Medical (AVNS) position steady in Q1 2026 at 76 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #590.

American National Bank & Trust first reported a position in AVNS in Q4 2014 and has held it in 6 quarters since. The position peaked at $2K in Q4 2014. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • American National Bank & Trust held 76 shares of Avanos Medical worth $1.06K as of Q1 2026.
  • American National Bank & Trust left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of American National Bank & Trust's portfolio in Q1 2026, its #590 holding.
  • American National Bank & Trust first reported a position in Avanos Medical in Q4 2014 and has held it in 6 quarters since.
  • American National Bank & Trust's Avanos Medical position peaked at $2K in Q4 2014.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on American National Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.